Peritoneal leukocyte survival and respiratory burst responses in patients treated with a low glucose degradation and high pH peritoneal dialysis fluid

International Journal of Artificial Organs

Volumn 26, Issue 2, 2003, Pages 121-128

  Jonasson, P ^a,b,c   Albrektsson, A ^a,b,c   Ljungman, S ^a,b,c   Wieslander, A ^a,b,c   Braide, Magnus ^a,b,c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c Gambro AB   (Sweden)

Author keywords

Apoptosis; Macrophages; Necrosis; Neutrophils; Peritoneal dialysis

Indexed keywords

DEGRADATION; DIALYSIS; GLUCOSE; MACROPHAGES; PATIENT MONITORING; PATIENT TREATMENT;

DEGRADATION PRODUCTS; GLUCOSE DEGRADATION; HIGH PH; LEUCOCYTES; NEUTROPHILE; PERITONEAL DIALYSIS; PERITONEAL DIALYSIS FLUIDS; PHYSIOLOGICAL PH; PRODUCT CONCENTRATION; RESPIRATORY BURST;

CELL DEATH;

GLUCOSE DEGRADATION PRODUCT; LIPOCORTIN 5; LUMINOL; PROPIDIUM IODIDE; ZYMOSAN; DIALYSIS FLUID; GLUCOSE;

ACIDITY; ADULT; AGED; APOPTOSIS; ARTICLE; BASOPHIL; CELL COUNT; CELL DEATH; CELL STRUCTURE; CELL SURVIVAL; CHEMOLUMINESCENCE; CHRONIC GLOMERULONEPHRITIS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETIC NEPHROPATHY; EFFLUENT; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; LEUKOCYTE; MACROPHAGE; MALE; MATHEMATICAL ANALYSIS; NEUTROPHIL; OPSONIZATION; PERITONEAL DIALYSIS; PERITONEUM CELL; PH; RESPIRATORY BURST; STATISTICAL ANALYSIS; COMPARATIVE STUDY; DRUG EFFECT; METABOLISM; METHODOLOGY; MIDDLE AGED; NECROSIS; PATHOLOGY; PHYSIOLOGY; THEORETICAL MODEL;

ADULT; AGED; APOPTOSIS; CELL SURVIVAL; DIALYSIS SOLUTIONS; FEMALE; GLUCOSE; HUMANS; HYDROGEN-ION CONCENTRATION; KIDNEY DISEASES; LEUKOCYTES; MALE; MIDDLE AGED; MODELS, THEORETICAL; NECROSIS; PERITONEAL DIALYSIS; RESPIRATORY BURST;

EID: 0038267059     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880302600205     Document Type: Article

References (37)

1. Topley N, Alobaidi HM, Davies M, Coles GA, Williams JD, Lloyd D. The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int 1988; 34: 404-11.
2. Duwe AK, Vas SI, Weatherhead JW. Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis, and bactericidal activity in vitro. Infect Immun 1981; 33: 130-135
3. Martinsson E, Wieslander A, Kjellstrand P, Boberg U. Toxicity of heat sterilized peritoneal dialysis fluids is derived from degradation of glucose. ASAIO J 1992; 38: M370-2.
4. Holmes CJ, Shockley TR. Strategies to reduce glucose exposure in peritoneal dialysis patients. Perit Dial Int 2000; 20 (suppl 2): S37-41.
5. Van Biesen W, Vanholder R, Lameire N. Recent developments in osmotic agents for peritoneal dialysis. Adv Ren Replace Ther 1998; 5: 218-31.
6. Feriani M. Use of different buffers in peritoneal dialysis. Semin Dial 2000; 13: 256-260.
7. Wieslander AP, Deppisch R, Svensson E, Forsback G, Speidel R, Rippe B. In vitro biocompatibility of a heat-sterilized, low-toxic, and less acidic fluid for peritoneal dialysis. Perit Dial Int 1995; 15: 158-164.
8. Wieslander AP, Andren AH, Nilsson Thorell C, Muscalu N, Kjellstrand PT, Rippe B. Are aldehydes in heat-sterilized peritoneal dialysis fluids toxic in vitro? Perit Dial Int 1995; 15: 348-52.
9. Jörres A, Witowski J, Korybalska K, et al. Effect of glucose degradation products (GDP) on human peritoneal mesothelial (HPMC) cell function. In: Oreopoulos DG, ed. The 18th Annual CAPD Conference. Nashville, Tennessee: Perit Dial Int 1998: 831.
10. Linden T, Deppisch R, Kjellstrand P, Forsbäck G, Wieslander A, 3,4-Dideoxyglucosone-3-Ene (3,4-DGE), a cytotoxic glucose degradation product in peritoneal dialysis fluids. Perit Dial Int 2002; 22: 102.
11. Wieslander AP, Nordin MK, Kjellstrand PT, Boberg UC. Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929. Kidney Int 1991; 40: 77-9.
12. Ing TS, Patel BP, Patel JA, et al. Effects of a pH 7.4, lactate-based and a pH 7.4, bicarbonate-based peritoneal dialysis solutions on neutrophil superoxide generation. Int J Artif Organs 1996; 19: 700-3.
13. Jonasson P, Bagge U, Wieslander A, Braide M. Heat-sterilized PD-fluid blocks leukocyte adhesion and increases flow velocity in rat peritoneal venules. Perit Dial Int 1996; 16 (suppl 1): S137-40.
14. Jonasson P, Braide M. Acute in vivo toxicity of heat-sterilized glucose PD fluids to rat peritoneal macrophages. Perit Dial Int 1998; 18: 376-81.
15. Jonasson P, Braide M. Kinetics and dose response of the effects of heated glucose PD fluids on the respiratory burst of rat peritoneal leukocytes. ASAIO J 2000; 46: 469-73.
16. White R, Barefield D, Ram S, Work J. Peritoneal dialysis solutions reverse the hemodynamic effects of nitric oxide synthesis inhibitors. Kidney Int 1995; 48: 1986-93.
17. Cendoroglo M, Sundaram S, Groves C, Ucci AA, Jaber BL Pereira BJ. Necrosis and apoptosis of polymorphonuclear cells exposed to peritoneal dialysis fluids in vitro. Kidney Int 1997; 52: 1626-34.
18. Cendoroglo M, Sundaram S, Jaber BL, Pereira BJ. Effect of glucose concentration, osmolality, and sterilization process of peritoneal dialysis fluids on cytokine production by peripheral blood mononuclear cells and polymorphonuclear cell functions in vitro. Am J Kidney Dis 1998; 31: 273-82.
19. Braide M, Jonasson P. In vivo exposure to heat-sterilized PD fluids inhibits the respiratory burst response of rat peritoneal neutrophils. American Society of Nephrology 31st Annual Meeting. Philadelphia, Pennsylvania, 1998.
20. Rippe B, Simonsen O, Wieslander A, Landgren C. Clinical and physiological effects of a new, less toxic and less acidic fluid for peritoneal dialysis. Perit Dial Int 1997; 17: 27-34.
21. Rippe B, Simonsen O, Heimburger O, et al. Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. Kidney Int 2001; 59: 348-57.
22. Schalkwijk C, Posthuma N, Ten Brink H, Wee P, Teerlink T. Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids. Perit Dial Int 1999; 19: 325-33.
23. Wieslander A, Forsback G, Svensson E, Linden T. Cytotoxicity, pH, and glucose degradation products in four different brands of PD fluid. Adv Perit Dial 1996; 12: 57-60.
24. Jones KH, Senft JA. An improved method to determine cell viability by simultaneous staining with fluorescein diacetate-propidium iodide. J Histochem Cytochem 1985; 33: 77-9.
25. Jin HM, Di YD, Xu QJ. Effects of commercial glucose-based peritoneal dialysates on peripheral blood phagocytes apoptosis. Perit Dial Int 1999; 19 (suppl 2): S388-93.
26. Homburg CH, De Haas M, Von Dem Borne AE, Verhoeven AJ, Reutelingsperger CP, Roos D. Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood 1995; 85: 532-40.
27. Jörres A, Topley N, Gahl GM. Biocompatibility of peritoneal dialysis fluids (Editorial). Int J Artif Organs 1992; 15: 79-83.
28. Smith RM, Curnutte JT. Molecular basis of chronic granulomatous disease. Blood 1991; 77: 673-86.
29. Hyslop PA, Hinshaw DB, Scraufstatter IU, Cochrane CG, Kunz S, Vosbeck K. Hydrogen peroxide as a potent bacteriostatic antibiotic: Implications for host defense. Free Radic Biol Med 1995; 19: 31-7.
30. Hampton MB, Kettle AJ, Winterbourn CC. Inside the neutrophil phagosome: Oxidants, myeloperoxidase, and bacterial killing. Blood 1998; 92: 3007-17.
31. 2-independent bactericidal system. J Clin Invest 1982; 69: 959-70.
32. Gresham HD, Zheleznyak A, Mormol JS, Brown EJ. Studies on the molecular mechanisms of human neutrophil Fc receptor-mediated phagocytosis. Evidence that a distinct pathway for activation of the respiratory burst results in reactive oxygen metabolite-dependent amplification of ingestion. J Biol Chem 1990; 265: 7819-26.
33. Salmon JE, Millard SS, Brogle NL, Kimberly RP. Fc gamma receptor IIIb enhances Fc gamma receptor IIa function in an oxidant-dependent and allele-sensitive manner. J Clin Invest 1995; 95: 2877-85.
34. Oclura M, Kitamura M. Oxidant stress incites spreading of macrophages via ERK/p38-SRE signalling pathways. In: Tischer CC, ed. American Society of Nephrology 31st Annual Meeting. Philadelphia, PA: Williams & Wilkins, 1998: 429A.
35. Suzuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med 1997; 22: 269-85.
36. Derevianko A, D'Amico R, Graeber T, Keeping H, Simms HH. Endogenous PMN-derived reactive oxygen intermediates provide feedback regulation on respiratory burst signal transduction. J Leukoc Biol 1997; 62: 268-76.
37. Nygren H, Braide M. The respiratory burst response of surface-adhering leukocytes - A cytotoxicity test of materials. Recent Res Dev Vaccum Sci & Tech 1999; 1: 21-44.